pancreatic cancer
Conditions
Interventions
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) the histopathology and (or) cytology diagnosis of pancreatic cancer, including: 1) the EUS or CT guided puncture biopsy; Fall off 2) ascites cytology; 3) probe under laparoscopy or laparotomy biopsy; (2) pancreatic cancer pathological types of ductal adenocarcinoma (including glands squamous carcinoma, mucinous carcinoma [] mucous sex of cystic carcinoma, liver samples, medullary carcinoma, adenocarcinoma, undifferentiated carcinoma, signet ring cell carcinoma with broken bone giant cell anaplastic carcinoma and other special subtype) and pathological types include around ampulla carcinoma group except the pancreatic head carcinoma of ampulla surrounding tissues malignant tumor (end of the common bile duct and duodenum papillary adenocarcinoma etc).
Exclusion criteria
Exclusion criteria: 1. tumor TNM staging in stage III or IV or generally poor patients; 2. parenteral nutrition or part of the patients with enteral nutrition; 3. chronic alcoholism and severe liver and kidney disease; 4. chemotherapy or radiotherapy patients; 5. have confirmed with the gut microbes causal correlation condition or disease patients (type II diabetes, sclerosis of arterial congee appearance, obesity (BMI > 30), liver cirrhosis, colorectal cancer, rheumatoid arthritis). 6. may affect the gut microbes species and metabolic disease, cholecystitis, appendicitis, various intestinal inflammatory diseases); 7. are taking affect gut microbes species and metabolism of drugs in patients with drugs (antibiotics, metformin, anti-rheumatism medicine and other may affect drug); 8. large gastrointestinal surgery patients; 9. diarrhea or constipation patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| gene;metabolites; | — |
Countries
China
Contacts
Public ContactBING PENG
West China Hospital, Sichuan university
Outcome results
None listed